Search PDMR transactions

Notifier
Name of person with notification obligation
Dag Andersson Tilk
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Dag Andersson Tilk
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Xvivo Perfusion Aktiebolag
Issuer´s LEI code
529900T8BM49AURSDO55
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Xvivoperfu Ak SE0004840718 Acquisition 325 Quantity 322.381538 SEK 10/11/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Xvivoperfu Ak SE0004840718 Acquisition 10/11/2021 NASDAQ STOCKHOLM AB 325 (Quantity) 322.381538 SEK
Total: 325
<< Back